Responsible Center: NASA JSC
Grant Monitor: Shea, Cami1e
Center Contact: 281-244-2017 shea@dsls.usra.edu
Unique ID: 7832
|
Solicitation / Funding Source: Directed Research
Grant/Contract No.: Directed Research
Project Type: GROUND
Flight Program:
TechPort: Yes |
No. of Post Docs:
No. of PhD Candidates:
No. of Master's Candidates:
No. of Bachelor's Candidates:
|
No. of PhD Degrees:
No. of Master's Degrees:
No. of Bachelor's Degrees:
|
|
Human Research Program Elements: |
(1) BHP:Behavioral Health & Performance (archival in 2017)
|
|
Human Research Program Risks: |
(1) BMed:Risk of Adverse Cognitive or Behavioral Conditions and Psychiatric Disorders
|
|
Human Research Program Gaps: |
(1) BMed-104:Given the potentially negative spaceflight associated CNS changes and behavioral experiences of stressors during long-duration missions (e.g., isolation, confinement, reduced sensory stimulation, altered gravity, space radiation), what are validated modifications to habitat/vehicle to mitigate stressors impacting on CNS / cognition / behavioral health?
|
|
Task Description: |
The proposed pilot study provides an opportunity to test the feasibility of a protocol to use with astronauts and other NASA personnel (e.g., flight surgeons, flight directors, and flight controllers) to assess potential carry over effects from sleep medications used during spaceflight operations (including overseas training periods), and following an abrupt awakening from sleep. This information is critically needed to establish optimal and individually tailored usage of sleep medications by key personnel relative to operational demands. The proposed protocol is a feasibility study that will determine the percentage change in sleep inertia from using a medication compared to normal sleep inertia. Subject participants will each choose a hypnotic as their preferred sleep aid; once an appropriate medication is identified, each subject volunteer, in a controlled setting in the Crew Quarters Facility at Johnson Space Center (JSC), will undergo several awakenings during two nights of sleep (one night with the medication, another night with a placebo). Cognitive performance, using a set of three measures, will be evaluated at each awakening. This process will occur under the direction of the study Principal Investigator, a NASA Flight Surgeon. |
|
Research Impact/Earth Benefits: |
|